Kira Pharmaceuticals

Kira Homepage

Cambridge, United States · Founded 2017

Employees
11–50
Founded
2017
Business Model
B2B
Last Round
Series BJan 2021
Rounds
3

About

Kira Pharmaceuticals is a clinical-stage global biotechnology company founded in 2017, headquartered in Cambridge, Massachusetts with offices in Suzhou and Shanghai, China, and Australia. The company is pioneering treatments for complement-mediated diseases using its proprietary LOGIC (Lead identification, Optimization and Attribute Generation, In-vivo Confirmation) platform. Since inception, Kira has built a robust pipeline of nine novel complement assets. The company's leadership team includes co-founders Wenru Song (President & Head of R&D) and Gonghua Pan, along with drug developers, protein engineers, and world-renowned complement biology experts.

Summary

Kira Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2017. Its most recent funding was a Series B round in Jan 2021. Investors include Quan Capital, RA Capital Management and Vivo Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJan 2021

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kira Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/kira-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/kira-pharmaceuticals" alt="Kira Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>